Skip to main content

Animations

MJFF Publications

7491 - 7500 of 8808 Results
Title
Year
  • Year
  • 2025
  • 2019
  • 2015
  • 2025
  • 2019
  • 2020
  • 2019
  • 2019
  • 2023
  • 2018
  • Summary Details
    OPEN
    Title: Glycation of alpha-synuclein enhances aggregation and neuroinflammatory responses
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-025-01159-w
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Bidirectional dopamine modulation of excitatory and inhibitory synaptic inputs to subthalamic neuron subsets containing α4β2 or α7 nAChRs
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2019.01.015
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.031
    Citation Count: 246
  • Summary Details
    RESTRICTED
    Title: The Progressive Supranuclear Palsy Clinical Deficits Scale accurately reflects functional as well as patient- and caregiver-reported outcomes
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108060
    Citation Count: 0
  • Summary Details
    OPEN
    Title: SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27770
    Citation Count: 25
  • Summary Details
    RESTRICTED
    Title: Robust identification of Parkinson's disease subtypes using radiomics and hybrid machine learning
    Journal Name: Computers in Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.compbiomed.2020.104142
    Citation Count: 46
  • Summary Details
    RESTRICTED
    Title: Expert comment to: Novel Xp21.1 deletion associated with unusual features in large McLeod syndrome kindred
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.024
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Single-pulse subthalamic deep brain stimulation reduces premotor-motor facilitation in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.08.003
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105954
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-018-0245-9
    Citation Count: 65
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.